Replimune Group, Inc. (REPL) Tops Q2 EPS by 14c

Replimune Group, Inc. (NASDAQ: REPL) reported Q2 EPS of ($0.68), $0.14 better than the analyst estimate of ($0.82).

For earnings history and earnings-related data on Replimune Group, Inc. (REPL) click here.

You May Also Be Interested In

• Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
• Computacenter Plc. (CCC:LN) PT Raised to GBP60 at JPMorgan
• RBC Capital Reiterates Outperform Rating on Aviva PLC (AV:LN) (AVVIY)